Human Proinsulin Quantikine ELISA Kit | hProinsulin QKit

• Product Details
• Product Summary
• Precision
• Recovery
• Linearity
• Additional Infomation
• Citations

Product Details

Assay Type

Solid Phase Sandwich ELISA

Format

96-well strip plate

Assay Length

4.5 hours

Sample Type & Volume Required Per Well

Serum (100 µL), EDTA Plasma (100 µL), Heparin Plasma (100 µL)

Sensitivity

1.43 pM

Assay Range

3.28 - 210 pM (Serum, Heparin Plasma, Cell Culture Supernates, EDTA Plasma)

Specificity

Natural and recombinant human Proinsulin.

Interference

Interference observed with 1 or more available related molecules.

目次に戻る

Product Summary

目次に戻る

Precision

	Intra-Assay Precision	Inter-Assay Precision
Sample
n
Mean
CV%

	Intra-Assay Precision			Inter-Assay Precision
Sample	1	2	3	1	2	3
n	20	20	20	20	20	20
Mean	21.1	62.7	119	18	55.1	109
Standard Deviation	0.44	0.745	1.4	1.9	3.97	6.91
CV%	2.1	1.2	1.2	10.6	7.2	6.3

目次に戻る

Recovery

Sample Type	Average % Recovery	Range %
Serum (n=4)	95	80-105
EDTA Plasma (n=4)	92	86-108
Heparin Plasma (n=4)	94	90-100

目次に戻る

Linearity

目次に戻る

Additional Infomation

Molecule Information

Proinsulin

Aliases

undefined

Entrez Gene IDs

3630 (Human); 16333 (Mouse)

Background

Proinsulin

Proinsulin is synthesized as a single chain, 110 amino acid (aa) preproprecursor that contains a 24 aa signal sequence and an 86 aa proinsulin. Following removal of the signal peptide, the proinsulin peptide undergoes further proteolysis to generate mature insulin, a 51 aa disulfide-linked dimer that consists of a 30 aa B chain (aa 25 - 54) bound to a 21 aa A chain (aa 90 - 110). The 34 aa intervening peptide (aa 55 - 89) that connects the B and A chains is termed the C-peptide. Human proinsulin shares 84% and 80% aa sequence identity with rat and bovine proinsulin, respectively. Most of the sequence variation between species occurs in the region of the C-peptide. This peptide generates a structural conformation that allows for the correct formation of the intrachain disulphide bonds.Insulin is a molecule that facilitates the cellular uptake of glucose. This is accomplished by regulating the appearance of membrane glucose transporters. Low insulin levels or lack of insulin are associated with type 2 and type 1 diabetes mellitus, respectively. These conditions are associated with an increased risk for microvascular complications such as retinopathy, nephropathy, and peripheral neuropathy.Proinsulin also circulates, but its physiological role is less well understood. It has approximately 25% of the activity of mature insulin, but it would seem unlikely to be a natural substitute for insulin. In type 2 diabetes, an elevated proinsulin-to-insulin ratio in the circulation is a well-known abnormality. This abnormality may represent either compromised proteolytic processing or a general inability to process increased levels of insulin precursor. Proinsulin will stimulate amylin secretion by beta-cells, and amyloid formation in pancreatic islets that promotes decreased beta-cell function. Studies also suggest that fasting serum proinsulin may be a better predictor of future type 2 diabetes than fasting insulin levels in obese children.

目次に戻る

Citations

目次に戻る